October 16th, 2026Genetic Analysis Links Insomnia Liability to Higher Inflammation MarkerGenetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.Read more
October 16th, 2026AJMC® in the Press, October 16, 2026Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.Read more
October 16th, 2026Medicaid Gender Care Rule May Face Uphill Legal BattleAlice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.Read more
October 16th, 2026FAQ: How Payers Can Ease Drug Cost Burdens for Patients, PhysiciansSiva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.Read more
October 16th, 2026Proinflammatory Diets Linked to Higher MASLD, MetALD MortalityProinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.Read more
October 15th, 2026Pathological Response Does Not Reliably Predict Survival in SarcomaInconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.Read more
October 15th, 2026Gene Silencers Cut ATTR-CM Events, Mostly in Patients Off StabilizersA meta-analysis of HELIOS-B and CARDIO-TTRansform found gene silencers reduced death and CV events, driven by patients not taking stabilizers.Read more
October 15th, 2026Review Backs ApoB to Flag Residual Risk That LDL-C Can MissApoB more directly reflects atherogenic particle burden than LDL-C, but missing outcome trials and assay variability still limit its routine use.Read more